Processa Pharmaceuticals (PCSA) Q3 2025 Earnings

7AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.03
-0.76
-0.49
-0.22

Details

Expected EPS
-0.22
Actual EPS
-0.25
Surprise EPS
-0.03
Surprise Percent
+13.64%

Description

Processa Pharmaceuticals (PCSA) has reported earnings of -0.25 per share for Q3 2025.

0 Comments

Share your thoughts